Weekly chemotherapy in advanced prostatic cancer.

This randomised phase II study was performed in order to evaluate the effectiveness of a weekly chemotherapy regimen in advanced prostatic carcinoma patients (stage D2) refractory to hormonal therapy. Seventy-two cases were studied: they were randomised in a 2:1 ratio to receive either epirubicin (3...

Descripción completa

Detalles Bibliográficos
Autores principales: Francini, G., Petrioli, R., Manganelli, A., Cintorino, M., Marsili, S., Aquino, A., Mondillo, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968505/
https://www.ncbi.nlm.nih.gov/pubmed/8512828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968505/
https://www.ncbi.nlm.nih.gov/pubmed/8512828

Ejemplares similares